共 18 条
[1]
Antonini A(2009)Behavioural adverse effects of dopaminergic treatments in Parkinson’s disease: incidence, neurobiological basis, management and prevention Drug Saf 32 475-488
[2]
Cilia R(2006)Compulsive eating and weight gain related to dopamine agonist use Mov Disord 21 524-529
[3]
Nirenberg MJ(2008)Alteration of eating behaviors in patients with Parkinson’s disease: possibly overlooked? Neurocase 14 480-484
[4]
Waters C(2007)Medication-related impulse control and repetitive behaviors in Parkinson’s disease Curr Opin Neurol 20 484-492
[5]
Miwa H(2008)Dopamine and impulse control disorders in Parkinson’s disease Ann Neurol 64 S93-S100
[6]
Kondo T(2004)Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial Clin Ther 26 1427-1435
[7]
Voon V(2006)Impulse control disorders in Parkinson’s disease Curr Neurol Neurosci Rep 6 302-306
[8]
Potenza MN(undefined)undefined undefined undefined undefined-undefined
[9]
Thomsen T(undefined)undefined undefined undefined undefined-undefined
[10]
Weintraub D(undefined)undefined undefined undefined undefined-undefined